Sign In
Buy EKSO
$11.80
+0 (+0%)
At Close: Jun 03, 2026
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
12:00pm, Monday, 26'th Aug 2024
Ekso Bionics EKSO has reached a significant milestone in terms of transforming mobility solutions, particularly for individuals with spinal cord injuries (SCI). The company recently secured initial re
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
08:12am, Tuesday, 30'th Jul 2024
Ekso Bionics (NASDAQ: EKSO ) stock is taking a beating on Tuesday following the release of the exoskeleton company's Q2 earnings report. The bad news for Ekso Bionics starts with its diluted earnings
Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript
10:10pm, Monday, 29'th Jul 2024
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates
06:45pm, Monday, 29'th Jul 2024
Ekso Bionics (EKSO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.31 per share a year ago.
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
04:05pm, Monday, 29'th Jul 2024
SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
08:00am, Monday, 22'nd Jul 2024
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
02:30pm, Wednesday, 26'th Jun 2024
Ekso Bionics (EKSO) announces a research partnership with Shepherd Center to create training and research programs for the Ekso devices.
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
04:05pm, Monday, 17'th Jun 2024
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso's Board
All You Need to Know About Ekso Bionics (EKSO) Rating Upgrade to Buy
01:01pm, Monday, 10'th Jun 2024
Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Prosthetic Market - A Global and Regional Analysis: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMark
Ekso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew Pinsky
08:00am, Friday, 10'th May 2024
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif.
Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript
07:39pm, Monday, 29'th Apr 2024
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q1 2024 Results Conference Call April 29, 2023 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo
Ekso Bionics Announces First Quarter 2024 Financial Results
04:05pm, Monday, 29'th Apr 2024
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical an
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
08:00am, Monday, 22'nd Apr 2024
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical an
